Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Robert James Glynn, Sc.D., Ph.D.

TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressDivision of Preventive Medicine
Brigham & Women's Hospital
900 Commonwealth Ave
Boston MA 02215
Phone617/278-0792
Fax617/734-1437
Other Positions
TitleProfessor in the Department of Biostatistics
InstitutionHarvard School of Public Health
DepartmentBiostatistics


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Choudhry NK, Glynn RJ, Avorn J, Lee JL, Brennan TA, Reisman L, Toscano M, Levin R, Matlin OS, Antman EM, Shrank WH. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: Medication adherence and clinical outcomes. Am Heart J. 2014 Jan; 167(1):51-58.e5.
    View in: PubMed
  2. Kulik A, Desai NR, Shrank WH, Antman EM, Glynn RJ, Levin R, Reisman L, Brennan T, Choudhry NK. Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event and Economic Evaluation (FREEE) Randomized Trial. Circulation. 2013 Sep 10; 128(26 Suppl 1):S219-25.
    View in: PubMed
  3. Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation. 2013 Sep 10; 128(11):1189-97.
    View in: PubMed
  4. Patrick AR, Franklin JM, Weinstein MC, Glynn RJ, Schneeweiss S. Sequential Value-of-Information Assessment for Prospective Drug Safety Monitoring Using Claims Databases: The Comparative Safety of Prasugrel v. Clopidogrel. Med Decis Making. 2013 Oct; 33(7):949-60.
    View in: PubMed
  5. Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, Mines D, Liu J, Schneeweiss S. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. J Am Heart Assoc. 2013; 2(4):e000208.
    View in: PubMed
  6. Rosner B, Glynn RJ, Tamimi RM, Chen WY, Colditz GA, Willett WC, Hankinson SE. Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. Am J Epidemiol. 2013 Jul 15; 178(2):296-308.
    View in: PubMed
  7. Everett BM, Pradhan AD, Solomon DH, Paynter N, Macfadyen J, Zaharris E, Gupta M, Clearfield M, Libby P, Hasan AA, Glynn RJ, Ridker PM. Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis. Am Heart J. 2013 Aug; 166(2):199-207.e15.
    View in: PubMed
  8. Polinski JM, Shrank WH, Glynn RJ, Schneeweiss S, Huskamp HA, Roebuck MC. Response letter to eltonsy and colleagues. J Am Geriatr Soc. 2013 May; 61(5):848-9.
    View in: PubMed
  9. Wang SV, Gagne JJ, Glynn RJ, Schneeweiss S. Case-crossover Studies of Therapeutics: Design Approaches to Addressing Time-varying Prognosis in Elderly Populations. Epidemiology. 2013 May; 24(3):375-8.
    View in: PubMed
  10. Rassen JA, Shelat AA, Franklin JM, Glynn RJ, Solomon DH, Schneeweiss S. Matching by propensity score in cohort studies with three treatment groups. Epidemiology. 2013 May; 24(3):401-9.
    View in: PubMed
  11. Mitta VP, Christen WG, Glynn RJ, Semba RD, Ridker PM, Rimm EB, Hankinson SE, Schaumberg DA. C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts. JAMA Ophthalmol. 2013 Apr 1; 131(4):507-13.
    View in: PubMed
  12. Djoussé L, Wilk JB, Hanson NQ, Glynn RJ, Tsai MY, Gaziano JM. Association between adiponectin and heart failure risk in the physicians' health study. Obesity (Silver Spring). 2013 Apr; 21(4):831-4.
    View in: PubMed
  13. Winter AC, Schürks M, Glynn RJ, Buring JE, Gaziano JM, Berger K, Kurth T. Vascular risk factors, cardiovascular disease, and restless legs syndrome in women. Am J Med. 2013 Mar; 126(3):220-227.e2.
    View in: PubMed
  14. Winter AC, Berger K, Glynn RJ, Buring JE, Gaziano JM, Schürks M, Kurth T. Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. Am J Med. 2013 Mar; 126(3):228-235.e2.
    View in: PubMed
  15. Tokede OA, Petrone AB, Hanson NQ, Tsai MY, Weir NA, Glynn RJ, Gaziano JM, Djoussé L. Plasma phospholipid trans fatty acids and risk of heart failure. Am J Clin Nutr. 2013 Apr; 97(4):698-705.
    View in: PubMed
  16. Matsumoto C, Hanson NQ, Tsai MY, Glynn RJ, Gaziano JM, Djoussé L. Plasma phospholipid saturated fatty acids and heart failure risk in the physicians' health study. Clin Nutr. 2013 Oct; 32(5):819-23.
    View in: PubMed
  17. Conen D, Glynn RJ, Sandhu RK, Tedrow UB, Albert CM. Risk factors for incident atrial fibrillation with and without left atrial enlargement in women. Int J Cardiol. 2013 Oct 3; 168(3):1894-9.
    View in: PubMed
  18. Mack CD, Glynn RJ, Brookhart MA, Carpenter WR, Meyer AM, Sandler RS, Stürmer T. Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf. 2013 Aug; 22(8):810-8.
    View in: PubMed
  19. Danik JS, Buring JE, Chasman DI, Zee RY, Ridker PM, Glynn RJ. Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21 483 women. J Thromb Haemost. 2013 Jan; 11(1):205-8.
    View in: PubMed
  20. Petrone AB, Weir N, Hanson NQ, Glynn R, Tsai MY, Gaziano JM, Djoussé L. Omega-6 fatty acids and risk of heart failure in the Physicians' Health Study. Am J Clin Nutr. 2013 Jan; 97(1):66-71.
    View in: PubMed
  21. Schneeweiss S, Rassen JA, Glynn RJ, Myers J, Daniel GW, Singer J, Solomon DH, Kim S, Rothman KJ, Liu J, Avorn J. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. BMC Med Res Methodol. 2012; 12:180.
    View in: PubMed
  22. Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2012 Nov 14; 308(18):1871-80.
    View in: PubMed
  23. Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE, Gaziano JM. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2012 Nov 7; 308(17):1751-60.
    View in: PubMed
  24. Kesselheim AS, Robertson CT, Myers JA, Rose SL, Gillet V, Ross KM, Glynn RJ, Joffe S, Avorn J. A randomized study of how physicians interpret research funding disclosures. N Engl J Med. 2012 Sep 20; 367(12):1119-27.
    View in: PubMed
  25. Huybrechts KF, Seeger JD, Rothman KJ, Glynn RJ, Avorn J, Schneeweiss S. Bias in comparative effectiveness studies due to regional variation in medical practice intensity: a legitimate concern, or much ado about nothing? Circ Cardiovasc Qual Outcomes. 2012 Sep 1; 5(5):e61-4.
    View in: PubMed
  26. Cheung WY, Schaefer K, May CW, Glynn RJ, Curtis LH, Stevenson LW, Setoguchi S. Enrollment and Events of Hospice Patients With Heart Failure vs. Cancer. J Pain Symptom Manage. 2013 Mar; 45(3):552-60.
    View in: PubMed
  27. Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012 Aug 11; 380(9841):565-71.
    View in: PubMed
  28. Slopen N, Glynn RJ, Buring JE, Lewis TT, Williams DR, Albert MA. Job strain, job insecurity, and incident cardiovascular disease in the Women's Health Study: results from a 10-year prospective study. PLoS One. 2012; 7(7):e40512.
    View in: PubMed
  29. Margulis AV, Mitchell AA, Gilboa SM, Werler MM, Mittleman MA, Glynn RJ, Hernandez-Diaz S. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol. 2012 Nov; 207(5):405.e1-7.
    View in: PubMed
  30. Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Christopher Roebuck M, Schneeweiss S. Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc. 2012 Aug; 60(8):1408-17.
    View in: PubMed
  31. Glynn RJ, Rosner B. Regression methods when the eye is the unit of analysis. Ophthalmic Epidemiol. 2012 Jun; 19(3):159-65.
    View in: PubMed
  32. Gagne JJ, Glynn RJ, Rassen JA, Walker AM, Daniel GW, Sridhar G, Schneeweiss S. Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system. Clin Pharmacol Ther. 2012 Jul; 92(1):80-6.
    View in: PubMed
  33. Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hernández-Díaz S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013 Jan; 22(1):16-24.
    View in: PubMed
  34. Glynn RJ, Gagne JJ, Schneeweiss S. Role of disease risk scores in comparative effectiveness research with emerging therapies. Pharmacoepidemiol Drug Saf. 2012 May; 21 Suppl 2:138-47.
    View in: PubMed
  35. Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012 May; 21 Suppl 2:69-80.
    View in: PubMed
  36. Polinski JM, Schneeweiss S, Glynn RJ, Lii J, Rassen JA. Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment. Pharmacoepidemiol Drug Saf. 2012 May; 21 Suppl 2:90-8.
    View in: PubMed
  37. Lunt M, Glynn RJ, Rothman KJ, Avorn J, Stürmer T. Propensity score calibration in the absence of surrogacy. Am J Epidemiol. 2012 Jun 15; 175(12):1294-302.
    View in: PubMed
  38. Mora S, Glynn RJ, Boekholdt SM, Nordestgaard BG, Kastelein JJ, Ridker PM. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). J Am Coll Cardiol. 2012 Apr 24; 59(17):1521-8.
    View in: PubMed
  39. Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Roebuck MC, Schneeweiss S. Beneficiaries with cardiovascular disease and thePart D coverage gap. Circ Cardiovasc Qual Outcomes. 2012 May; 5(3):387-95.
    View in: PubMed
  40. Christen WG, Glynn RJ, Sesso HD, Kurth T, Macfadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM. Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 2012 Aug; 119(8):1642-9.
    View in: PubMed
  41. Glynn RJ. Complex relations of genetic polymorphisms with nutritionally influenced biomarkers. Am J Clin Nutr. 2012 May; 95(5):1001-2.
    View in: PubMed
  42. Winter AC, Schürks M, Glynn RJ, Buring JE, Gaziano JM, Berger K, Kurth T. Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. BMJ Open. 2012; 2(2):e000866.
    View in: PubMed
  43. Novack V, MacFadyen J, Malhotra A, Almog Y, Glynn RJ, Ridker PM. The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial. CMAJ. 2012 Apr 17; 184(7):E367-72.
    View in: PubMed
  44. Jimenez M, Chiuve SE, Glynn RJ, Stampfer MJ, Camargo CA, Willett WC, Manson JE, Rexrode KM. Alcohol consumption and risk of stroke in women. Stroke. 2012 Apr; 43(4):939-45.
    View in: PubMed
  45. Gagne JJ, Rassen JA, Walker AM, Glynn RJ, Schneeweiss S. Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules. Epidemiology. 2012 Mar; 23(2):238-46.
    View in: PubMed
  46. Polinski JM, Brookhart MA, Glynn RJ, Schneeweiss S. Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance. J Clin Psychopharmacol. 2012 Feb; 32(1):3-10.
    View in: PubMed
  47. Fitzgerald KC, Chiuve SE, Buring JE, Ridker PM, Glynn RJ. Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism. J Thromb Haemost. 2012 Feb; 10(2):189-98.
    View in: PubMed
  48. Gagne JJ, Walker AM, Glynn RJ, Rassen JA, Schneeweiss S. An event-based approach for comparing the performance of methods for prospective medical product monitoring. Pharmacoepidemiol Drug Saf. 2012 Jun; 21(6):631-9.
    View in: PubMed
  49. Horne BD, Lenzini PA, Wadelius M, Jorgensen AL, Kimmel SE, Ridker PM, Eriksson N, Anderson JL, Pirmohamed M, Limdi NA, Pendleton RC, McMillin GA, Burmester JK, Kurnik D, Stein CM, Caldwell MD, Eby CS, Rane A, Lindh JD, Shin JG, Kim HS, Angchaisuksiri P, Glynn RJ, Kronquist KE, Carlquist JF, Grice GR, Barrack RL, Li J, Gage BF. Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. Thromb Haemost. 2012 Feb; 107(2):232-40.
    View in: PubMed
  50. Peña JM, MacFadyen J, Glynn RJ, Ridker PM. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur Heart J. 2012 Feb; 33(4):531-7.
    View in: PubMed
  51. Lee TC, Glynn RJ, Peña JM, Paynter NP, Conen D, Ridker PM, Pradhan AD, Buring JE, Albert MA. Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. PLoS One. 2011; 6(12):e27670.
    View in: PubMed
  52. Kesselheim AS, Darby D, Studdert DM, Glynn R, Levin R, Avorn J. False Claims Act prosecution did not deter off-label drug use in the case of neurontin. Health Aff (Millwood). 2011 Dec; 30(12):2318-27.
    View in: PubMed
  53. Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011 Dec 1; 365(22):2088-97.
    View in: PubMed
  54. Schneeweiss S, Gagne JJ, Glynn RJ, Ruhl M, Rassen JA. Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development. Clin Pharmacol Ther. 2011 Dec; 90(6):777-90.
    View in: PubMed
  55. Myers JA, Rassen JA, Gagne JJ, Huybrechts KF, Schneeweiss S, Rothman KJ, Joffe MM, Glynn RJ. Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol. 2011 Dec 1; 174(11):1213-22.
    View in: PubMed
  56. Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, Schneeweiss S. Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap. PLoS Med. 2011 Aug; 8(8):e1001075.
    View in: PubMed
  57. Powell TM, Glynn RJ, Buring JE, Creager MA, Ridker PM, Pradhan AD. The relative importance of systolic versus diastolic blood pressure control and incident symptomatic peripheral artery disease in women. Vasc Med. 2011 Aug; 16(4):239-46.
    View in: PubMed
  58. Schmidt M, Christiansen CF, Horváth-Puhó E, Glynn RJ, Rothman KJ, Sørensen HT. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost. 2011 Jul; 9(7):1326-33.
    View in: PubMed
  59. Albert MA, Glynn RJ, Fonseca FA, Lorenzatti AJ, Ferdinand KC, MacFadyen JG, Ridker PM. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Am Heart J. 2011 Jul; 162(1):106-14.e2.
    View in: PubMed
  60. Rassen JA, Solomon DH, Glynn RJ, Schneeweiss S. Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic "matrix design". Pharmacoepidemiol Drug Saf. 2011 Jul; 20(7):675-83.
    View in: PubMed
  61. Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA. 2011 May 25; 305(20):2080-7.
    View in: PubMed
  62. Rassen JA, Glynn RJ, Brookhart MA, Schneeweiss S. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol. 2011 Jun 15; 173(12):1404-13.
    View in: PubMed
  63. Li Q, Glynn RJ, Dreyer NA, Liu J, Mogun H, Setoguchi S. Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients. Pharmacoepidemiol Drug Saf. 2011 Jul; 20(7):700-8.
    View in: PubMed
  64. Patrick AR, Shrank WH, Glynn RJ, Solomon DH, Dormuth CR, Avorn J, Cadarette SM, Mogun H, Brookhart MA. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health. 2011 Jun; 14(4):513-20.
    View in: PubMed
  65. Ridker PM, MacFadyen JG, Glynn RJ, Chasman DI. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention. Circ Cardiovasc Genet. 2011 Jun; 4(3):312-7.
    View in: PubMed
  66. Christen WG, Schaumberg DA, Glynn RJ, Buring JE. Dietary ?-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch Ophthalmol. 2011 Jul; 129(7):921-9.
    View in: PubMed
  67. Patrick AR, Schneeweiss S, Brookhart MA, Glynn RJ, Rothman KJ, Avorn J, Stürmer T. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf. 2011 Jun; 20(6):551-9.
    View in: PubMed
  68. Choudhry NK, Patrick AR, Glynn RJ, Avorn J. The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. J Am Coll Cardiol. 2011 Feb 15; 57(7):784-91.
    View in: PubMed
  69. Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011 Jul; 64(7):749-59.
    View in: PubMed
  70. Brookhart MA, Solomon DH, Glynn RJ, Ridker PM. Effect of rosuvastatin on hemoglobin levels in patients with anemia and low-grade inflammation: a post hoc analysis of the JUPITER trial. J Clin Pharmacol. 2011 Oct; 51(10):1483-7.
    View in: PubMed
  71. Solomon DH, Rassen JA, Glynn RJ, Garneau K, Levin R, Lee J, Schneeweiss S. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med. 2010 Dec 13; 170(22):1979-86.
    View in: PubMed
  72. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Arch Intern Med. 2010 Dec 13; 170(22):1968-76.
    View in: PubMed
  73. Baer HJ, Glynn RJ, Hu FB, Hankinson SE, Willett WC, Colditz GA, Stampfer M, Rosner B. Risk factors for mortality in the nurses' health study: a competing risks analysis. Am J Epidemiol. 2011 Feb 1; 173(3):319-29.
    View in: PubMed
  74. Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010; 341:c5702.
    View in: PubMed
  75. Christen WG, Glynn RJ, Sesso HD, Kurth T, MacFadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM. Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol. 2010 Nov; 128(11):1397-405.
    View in: PubMed
  76. Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Stürmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf. 2010 Dec; 19(12):1248-55.
    View in: PubMed
  77. Rosner B, Glynn RJ. Power and sample size estimation for the clustered wilcoxon test. Biometrics. 2011 Jun; 67(2):646-53.
    View in: PubMed
  78. Ridker PM, Glynn RJ. The JUPITER Trial: responding to the critics. Am J Cardiol. 2010 Nov 1; 106(9):1351-6.
    View in: PubMed
  79. Terry PD, Glynn RJ, Buring JE, Sesso HD. Hypertension and risk of death from external causes in the Physicians' Health Study enrollment cohort. Int J Public Health. 2011 Apr; 56(2):231-5.
    View in: PubMed
  80. Ridker PM, Paynter NP, Danik JS, Glynn RJ. Interpretation of Mendelian randomization studies and the search for causal pathways in atherothrombosis: the need for caution. Metab Syndr Relat Disord. 2010 Dec; 8(6):465-9.
    View in: PubMed
  81. Ridker PM, Macfadyen JG, Nordestgaard BG, Koenig W, Kastelein JJ, Genest J, Glynn RJ. Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk". Circ Cardiovasc Qual Outcomes. 2010 Sep; 3(5):447-52.
    View in: PubMed
  82. Stürmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol. 2010 Oct 1; 172(7):843-54.
    View in: PubMed
  83. Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, Mora S, MacFadyen JG, Glynn RJ, Kastelein JJ. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet. 2010 Jul 31; 376(9738):333-9.
    View in: PubMed
  84. Setoguchi S, Glynn RJ, Stedman M, Flavell CM, Levin R, Stevenson LW. Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J. 2010 Jul; 160(1):139-44.
    View in: PubMed
  85. Flint AJ, Rexrode KM, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, Rimm EB. Body mass index, waist circumference, and risk of coronary heart disease: A prospective study among men and women. Obes Res Clin Pract. 2010 Jul-Sep; 4(3):e163-246.
    View in: PubMed
  86. Ridker PM, MacFadyen J, Libby P, Glynn RJ. Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Am J Cardiol. 2010 Jul 15; 106(2):204-9.
    View in: PubMed
  87. Kenfield SA, Wei EK, Rosner BA, Glynn RJ, Stampfer MJ, Colditz GA. Burden of smoking on cause-specific mortality: application to the Nurses' Health Study. Tob Control. 2010 Jun; 19(3):248-54.
    View in: PubMed
  88. Brookhart MA, Stürmer T, Glynn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research: challenges and potential approaches. Med Care. 2010 Jun; 48(6 Suppl):S114-20.
    View in: PubMed
  89. Albert MA, Cozier Y, Ridker PM, Palmer JR, Glynn RJ, Rose L, Halevy N, Rosenberg L. Perceptions of race/ethnic discrimination in relation to mortality among Black women: results from the Black Women's Health Study. Arch Intern Med. 2010 May 24; 170(10):896-904.
    View in: PubMed
  90. Ridker PM, Glynn RJ. JUPITER, rosuvastatin, and the European Medicines Agency. Lancet. 2010 Jun 12; 375(9731):2071.
    View in: PubMed
  91. Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010 Apr 20; 152(8):488-96, W174.
    View in: PubMed
  92. Conen D, Chae CU, Guralnik JM, Glynn RJ. Influence of blood pressure and blood pressure change on the risk of congestive heart failure in the elderly. Swiss Med Wkly. 2010 Apr 3; 140(13-14):202-8.
    View in: PubMed
  93. Glynn RJ. The USPSTF recommendation statement on coronary heart disease risk assessment. Ann Intern Med. 2010 Mar 16; 152(6):403; author reply 405-6.
    View in: PubMed
  94. Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol. 2010 Mar 23; 55(12):1266-73.
    View in: PubMed
  95. Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation. 2010 Mar 9; 121(9):1069-77.
    View in: PubMed
  96. Christen WG, Glynn RJ, Chew EY, Buring JE. Vitamin E and age-related macular degeneration in a randomized trial of women. Ophthalmology. 2010 Jun; 117(6):1163-8.
    View in: PubMed
  97. Glynn RJ. Promises and limitations of mendelian randomization for evaluation of biomarkers. Clin Chem. 2010 Mar; 56(3):388-90.
    View in: PubMed
  98. Everett BM, Glynn RJ, MacFadyen JG, Ridker PM. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation. 2010 Jan 5; 121(1):143-50.
    View in: PubMed
  99. Schneeweiss S, Glynn RJ, Avorn J, Mamdani M, Mogun H, Solomon DH. NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1134-42.
    View in: PubMed
  100. Rassen JA, Mittleman MA, Glynn RJ, Alan Brookhart M, Schneeweiss S. Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention. Eur Heart J. 2010 Mar; 31(5):561-72.
    View in: PubMed
  101. Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. J Thromb Haemost. 2010 Jan; 8(1):95-100.
    View in: PubMed
  102. Christen WG, Glynn RJ, Chew EY, Buring JE. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology. 2009 Dec; 116(12):2386-92.
    View in: PubMed
  103. Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circ Cardiovasc Qual Outcomes. 2009 Nov; 2(6):616-23.
    View in: PubMed
  104. Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, Rimm EB. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring). 2010 Feb; 18(2):377-83.
    View in: PubMed
  105. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009 Jul; 20(4):512-22.
    View in: PubMed
  106. Flint AJ, Hu FB, Glynn RJ, Jensen MK, Franz M, Sampson L, Rimm EB. Whole grains and incident hypertension in men. Am J Clin Nutr. 2009 Sep; 90(3):493-8.
    View in: PubMed
  107. Dormuth CR, Neumann P, Maclure M, Glynn RJ, Schneeweiss S. Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications. Med Care. 2009 May; 47(5):508-16.
    View in: PubMed
  108. Glynn RJ. Methodological issues affecting estimates of bleeding risks and consequences after venous thromboembolism. Thromb Haemost. 2009 May; 101(5):797-8.
    View in: PubMed
  109. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009 Apr 28; 119(16):2146-52.
    View in: PubMed
  110. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol. 2009 Dec; 62(12):1226-32.
    View in: PubMed
  111. Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA. Statin adherence and risk of accidents: a cautionary tale. Circulation. 2009 Apr 21; 119(15):2051-7.
    View in: PubMed
  112. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol. 2009 Dec; 62(12):1233-41.
    View in: PubMed
  113. Zee RY, Bubes V, Shrivastava S, Ridker PM, Glynn RJ. Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Clin Chim Acta. 2009 Apr; 402(1-2):189-92.
    View in: PubMed
  114. Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009 Apr 30; 360(18):1851-61.
    View in: PubMed
  115. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet. 2009 Apr 4; 373(9670):1175-82.
    View in: PubMed
  116. Conen D, Glynn RJ, Ridker PM, Buring JE, Albert MA. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J. 2009 Jun; 30(11):1378-84.
    View in: PubMed
  117. Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, Albert CM. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol. 2009 Mar 17; 53(11):950-8.
    View in: PubMed
  118. Glynn RJ, Rosner B, Christen WG. Evaluation of risk factors for cataract types in a competing risks framework. Ophthalmic Epidemiol. 2009 Mar-Apr; 16(2):98-106.
    View in: PubMed
  119. Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med. 2009 Feb 23; 169(4):335-41.
    View in: PubMed
  120. Shrank WH, Choudhry NK, Solomon DH, Snedden TM, Lee TH, Glynn RJ, Brown TV, Jolda C, Spetman M, Brookhart MA, Schneeweiss S, Avorn J. Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial. Am Heart J. 2009 Apr; 157(4):613-9.
    View in: PubMed
  121. Everett BM, Glynn RJ, Buring JE, Ridker PM. Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women. J Thromb Haemost. 2009 Apr; 7(4):588-96.
    View in: PubMed
  122. Zee RY, Glynn RJ, Cheng S, Steiner L, Rose L, Ridker PM. An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study. Circ Cardiovasc Genet. 2009 Feb; 2(1):57-62.
    View in: PubMed
  123. Lunt M, Solomon D, Rothman K, Glynn R, Hyrich K, Symmons DP, Stürmer T. Different methods of balancing covariates leading to different effect estimates in the presence of effect modification. Am J Epidemiol. 2009 Apr 1; 169(7):909-17.
    View in: PubMed
  124. Glynn RJ, MacFadyen JG, Ridker PM. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. Clin Chem. 2009 Feb; 55(2):305-12.
    View in: PubMed
  125. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Sesso HD, Buring JE. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2009 Jan 7; 301(1):52-62.
    View in: PubMed
  126. Rassen JA, Schneeweiss S, Glynn RJ, Mittleman MA, Brookhart MA. Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol. 2009 Feb 1; 169(3):273-84.
    View in: PubMed
  127. Setoguchi S, Earle CC, Glynn R, Stedman M, Polinski JM, Corcoran CP, Haas JS. Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol. 2008 Dec 10; 26(35):5671-8.
    View in: PubMed
  128. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008 Nov 12; 300(18):2123-33.
    View in: PubMed
  129. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov 20; 359(21):2195-207.
    View in: PubMed
  130. Albert MA, Ravenell J, Glynn RJ, Khera A, Halevy N, de Lemos JA. Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. Am Heart J. 2008 Dec; 156(6):1103-9.
    View in: PubMed
  131. Kurth T, Glynn RJ. Predicting outcomes in CKD. Am J Kidney Dis. 2008 Oct; 52(4):635-7.
    View in: PubMed
  132. Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, Schaumberg DA. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care. 2008 Dec; 31(12):2338-43.
    View in: PubMed
  133. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study. J Hypertens. 2008 Sep; 26(9):1780-6.
    View in: PubMed
  134. Solomon DH, Glynn RJ, Rothman KJ, Schneeweiss S, Setoguchi S, Mogun H, Avorn J, Stürmer T. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis Rheum. 2008 Aug 15; 59(8):1097-104.
    View in: PubMed
  135. Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J. 2008 Jul; 156(1):31-6.
    View in: PubMed
  136. Setoguchi S, Schneeweiss S, Brookhart MA, Glynn RJ, Cook EF. Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf. 2008 Jun; 17(6):546-55.
    View in: PubMed
  137. Rao RS, Glickman ME, Glynn RJ. Stopping rules for surveys with multiple waves of nonrespondent follow-up. Stat Med. 2008 May 30; 27(12):2196-213.
    View in: PubMed
  138. Rosner B, Glynn RJ. Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models. Biometrics. 2009 Mar; 65(1):188-97.
    View in: PubMed
  139. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 1; 51(13):1247-54.
    View in: PubMed
  140. Everett BM, Glynn RJ, Danielson E, Ridker PM. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial. Clin Ther. 2008 Apr; 30(4):661-72.
    View in: PubMed
  141. Conen D, Everett BM, Glynn RJ, Ridker PM. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. Heart. 2008 Mar; 94(3):e13.
    View in: PubMed
  142. Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther. 2008 Sep; 84(3):326-31.
    View in: PubMed
  143. Dormuth CR, Maclure M, Glynn RJ, Neumann P, Brookhart AM, Schneeweiss S. Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications. Clin Ther. 2008; 30 Spec No:1038-50.
    View in: PubMed
  144. Christen WG, Liu S, Glynn RJ, Gaziano JM, Buring JE. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol. 2008 Jan; 126(1):102-9.
    View in: PubMed
  145. Wolin KY, Lee IM, Colditz GA, Glynn RJ, Fuchs C, Giovannucci E. Leisure-time physical activity patterns and risk of colon cancer in women. Int J Cancer. 2007 Dec 15; 121(12):2776-81.
    View in: PubMed
  146. Christen WG, Glynn RJ, Chew EY, Buring JE. Vitamin E and age-related cataract in a randomized trial of women. Ophthalmology. 2008 May; 115(5):822-829.e1.
    View in: PubMed
  147. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms are not associated with the risk of incident type 2 diabetes mellitus: a prospective cohort study. J Intern Med. 2008 Apr; 263(4):376-85.
    View in: PubMed
  148. Grodstein F, Kang JH, Glynn RJ, Cook NR, Gaziano JM. A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med. 2007 Nov 12; 167(20):2184-90.
    View in: PubMed
  149. Stürmer T, Buring JE, Glynn RJ. Aspirin and nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: weighing the evidence. Ann Intern Med. 2007 Nov 6; 147(9):674; author reply 674-5.
    View in: PubMed
  150. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Natriuretic peptide precursor a gene polymorphisms and risk of blood pressure progression and incident hypertension. Hypertension. 2007 Dec; 50(6):1114-9.
    View in: PubMed
  151. Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol. 2007 Dec 1; 100(11):1659-64.
    View in: PubMed
  152. Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med. 2007 Oct 16; 147(8):525-33.
    View in: PubMed
  153. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J. 2007 Dec; 28(23):2937-43.
    View in: PubMed
  154. Glynn RJ, Brookhart MA, Stedman M, Avorn J, Solomon DH. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care. 2007 Oct; 45(10 Supl 2):S38-43.
    View in: PubMed
  155. Schneeweiss S, Patrick AR, Stürmer T, Brookhart MA, Avorn J, Maclure M, Rothman KJ, Glynn RJ. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007 Oct; 45(10 Supl 2):S131-42.
    View in: PubMed
  156. Stürmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care. 2007 Oct; 45(10 Supl 2):S158-65.
    View in: PubMed
  157. Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation. 2007 Sep 25; 116(13):1497-503.
    View in: PubMed
  158. Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ. 2007 Sep 1; 335(7617):432.
    View in: PubMed
  159. Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ. Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction. Am J Manag Care. 2007 Aug; 13(8):445-52.
    View in: PubMed
  160. Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 1; 100(7):1061-7.
    View in: PubMed
  161. Albert MA, Glynn RJ, Buring JE, Ridker PM. Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis. 2008 Mar; 197(1):297-302.
    View in: PubMed
  162. Rosner B, Glynn RJ, Lee ML. A nonparametric test for observational non-normally distributed ophthalmic data with eye-specific exposures and outcomes. Ophthalmic Epidemiol. 2007 Jul-Aug; 14(4):243-50.
    View in: PubMed
  163. Wolin KY, Glynn RJ, Colditz GA, Lee IM, Kawachi I. Long-term physical activity patterns and health-related quality of life in U.S. women. Am J Prev Med. 2007 Jun; 32(6):490-9.
    View in: PubMed
  164. Setoguchi S, Solomon DH, Glynn RJ, Cook EF, Levin R, Schneeweiss S. Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data. Cancer Causes Control. 2007 Jun; 18(5):561-9.
    View in: PubMed
  165. Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Circulation. 2007 Apr 24; 115(16):2128-35.
    View in: PubMed
  166. Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ. Performance of propensity score calibration--a simulation study. Am J Epidemiol. 2007 May 15; 165(10):1110-8.
    View in: PubMed
  167. Huang PY, Buring JE, Ridker PM, Glynn RJ. Awareness, accuracy, and predictive validity of self-reported cholesterol in women. J Gen Intern Med. 2007 May; 22(5):606-13.
    View in: PubMed
  168. Albert MA, Glynn RJ, Buring JE, Ridker PM. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. Am J Cardiol. 2007 May 1; 99(9):1246-51.
    View in: PubMed
  169. Christen WG, Manson JE, Glynn RJ, Gaziano JM, Chew EY, Buring JE, Hennekens CH. Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Arch Ophthalmol. 2007 Mar; 125(3):333-9.
    View in: PubMed
  170. Schaumberg DA, Christen WG, Buring JE, Glynn RJ, Rifai N, Ridker PM. High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol. 2007 Mar; 125(3):300-5.
    View in: PubMed
  171. Rosner B, Glynn RJ. Interval estimation for rank correlation coefficients based on the probit transformation with extension to measurement error correction of correlated ranked data. Stat Med. 2007 Feb 10; 26(3):633-46.
    View in: PubMed
  172. Glynn RJ, Goldhaber SZ, Ridker PM. D-dimer and duration of anticoagulation. N Engl J Med. 2007 Jan 25; 356(4):422-3; author reply 423.
    View in: PubMed
  173. Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ. Propensity Score Calibration and its Alternatives. Am J Epidemiol. 2007; 165(10):1122-1123.
    View in: PubMed
  174. Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation. 2007 Jan 2; 115(1):27-33.
    View in: PubMed
  175. Stürmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2391-7.
    View in: PubMed
  176. Rosner B, Glynn RJ, Lee ML. Extension of the rank sum test for clustered data: two-group comparisons with group membership defined at the subunit level. Biometrics. 2006 Dec; 62(4):1251-9.
    View in: PubMed
  177. Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation. 2006 Dec 12; 114(24):2619-26.
    View in: PubMed
  178. Stürmer T, Rothman KJ, Glynn RJ. Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf. 2006 Oct; 15(10):698-709.
    View in: PubMed
  179. Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, Cook EF, Carney G, Schneeweiss S. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Sep; 54(9):2757-64.
    View in: PubMed
  180. Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Deitcher S, Shrivastava S, Ridker PM. Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost. 2006 Oct; 4(10):2199-203.
    View in: PubMed
  181. Glynn RJ. Commentary: genes as instruments for evaluation of markers and causes. Int J Epidemiol. 2006 Aug; 35(4):932-4.
    View in: PubMed
  182. Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2006 Jun; 4(6):1208-14.
    View in: PubMed
  183. Dormuth CR, Glynn RJ, Neumann P, Maclure M, Brookhart AM, Schneeweiss S. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Clin Ther. 2006 Jun; 28(6):964-78; discussion 962-3.
    View in: PubMed
  184. Stürmer T, Buring JE, Lee IM, Kurth T, Gaziano JM, Glynn RJ. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use. Am J Med. 2006 Jun; 119(6):494-502.
    View in: PubMed
  185. Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol. 2006 Aug; 59(8):819-28.
    View in: PubMed
  186. Ridker PM, Danielson E, Rifai N, Glynn RJ. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial. Hypertension. 2006 Jul; 48(1):73-9.
    View in: PubMed
  187. Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum. 2006 May; 54(5):1378-89.
    View in: PubMed
  188. Winkelmayer WC, Benner JS, Glynn RJ, Schneeweiss S, Wang PS, Brookhart MA, Levin R, Jackson JD, Avorn J. Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making. 2006 May-Jun; 26(3):247-54.
    View in: PubMed
  189. Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T. Variable selection for propensity score models. Am J Epidemiol. 2006 Jun 15; 163(12):1149-56.
    View in: PubMed
  190. Schneeweiss S, Maclure M, Dormuth CR, Glynn RJ, Canning C, Avorn J. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Clin Pharmacol Ther. 2006 Apr; 79(4):379-88.
    View in: PubMed
  191. Rosner B, Glynn RJ, Lee ML. The Wilcoxon signed rank test for paired comparisons of clustered data. Biometrics. 2006 Mar; 62(1):185-92.
    View in: PubMed
  192. Glynn RJ, Schneeweiss S, Stürmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol. 2006 Mar; 98(3):253-9.
    View in: PubMed
  193. Sesso HD, Gaziano JM, Glynn RJ, Buring JE. Value of an Endpoints Committee versus the use of nosologists for validating cause of death. Contemp Clin Trials. 2006 Aug; 27(4):333-9.
    View in: PubMed
  194. Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, Robins JM. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006 Feb 1; 163(3):262-70.
    View in: PubMed
  195. Brookhart MA, Solomon DH, Wang P, Glynn RJ, Avorn J, Schneeweiss S. Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors. J Clin Epidemiol. 2006 Jan; 59(1):18-25.
    View in: PubMed
  196. Stürmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006 May; 59(5):437-47.
    View in: PubMed
  197. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005 Nov 15; 162(10):975-82.
    View in: PubMed
  198. Perlis RH, Ganz DA, Avorn J, Schneeweiss S, Glynn RJ, Smoller JW, Wang PS. Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model. J Clin Psychopharmacol. 2005 Oct; 25(5):427-34.
    View in: PubMed
  199. Kurth T, Hennekens CH, Stürmer T, Sesso HD, Glynn RJ, Buring JE, Gaziano JM. Analgesic use and risk of subsequent hypertension in apparently healthy men. Arch Intern Med. 2005 Sep 12; 165(16):1903-9.
    View in: PubMed
  200. Albert MA, Glynn RJ, Wolfert RL, Ridker PM. The effect of statin therapy on lipoprotein associated phospholipase A2 levels. Atherosclerosis. 2005 Sep; 182(1):193-8.
    View in: PubMed
  201. Avorn J, Schneeweiss S, Sudarsky LR, Benner J, Kiyota Y, Levin R, Glynn RJ. Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol. 2005 Aug; 62(8):1242-8.
    View in: PubMed
  202. Stürmer T, Schneeweiss S, Avorn J, Glynn RJ. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol. 2005 Aug 1; 162(3):279-89.
    View in: PubMed
  203. Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, Glynn RJ. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension. 2005 Aug; 46(2):273-9.
    View in: PubMed
  204. Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med. 2005 May 9; 165(9):1048-53.
    View in: PubMed
  205. Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005 May 17; 111(19):2446-53.
    View in: PubMed
  206. Hudson JI, Pope HG, Glynn RJ. The cross-sectional cohort study: an underutilized design. Epidemiology. 2005 May; 16(3):355-9.
    View in: PubMed
  207. Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005 May 1; 161(9):891-8.
    View in: PubMed
  208. Strohsnitter WC, Noller KL, Titus-Ernstoff L, Troisi R, Hatch EE, Poole C, Glynn RJ, Hsieh CC. Breast cancer incidence in women prenatally exposed to maternal cigarette smoke. Epidemiology. 2005 May; 16(3):342-5.
    View in: PubMed
  209. Bowman TS, Sesso HD, Glynn RJ, Gaziano JM. JNC 7 category and risk of cardiovascular death in men: are there differences by age? Am J Geriatr Cardiol. 2005 May-Jun; 14(3):126-31; quiz 132-3.
    View in: PubMed
  210. Wang PS, Schneeweiss S, Brookhart MA, Glynn RJ, Mogun H, Patrick AR, Avorn J. Suboptimal antidepressant use in the elderly. J Clin Psychopharmacol. 2005 Apr; 25(2):118-26.
    View in: PubMed
  211. Schneeweiss S, Glynn RJ, Avorn J, Solomon DH. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. J Clin Epidemiol. 2005 Jan; 58(1):98-102.
    View in: PubMed
  212. Scranton RE, Sesso HD, Glynn RJ, Levenson JW, Stedman M, Gagnon D, Gaziano JM. Characteristics associated with differences in reported versus measured total cholesterol among male physicians. J Prim Prev. 2005 Jan; 26(1):51-61.
    View in: PubMed
  213. Schneeweiss S, Glynn RJ, Tsai EH, Avorn J, Solomon DH. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology. 2005 Jan; 16(1):17-24.
    View in: PubMed
  214. Christen W, Glynn R, Sperduto R, Chew E, Buring J. Age-related cataract in a randomized trial of beta-carotene in women. Ophthalmic Epidemiol. 2004 Dec; 11(5):401-12.
    View in: PubMed
  215. Glynn RJ, Rosner B. Multiple imputation to estimate the association between eyes in disease progression with interval-censored data. Stat Med. 2004 Nov 15; 23(21):3307-18.
    View in: PubMed
  216. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 2004 Nov; 53(11):2883-92.
    View in: PubMed
  217. Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med. 2004 Jul 26; 164(14):1567-72.
    View in: PubMed
  218. Glynn RJ, Cook NR. C-reactive protein and coronary heart disease. N Engl J Med. 2004 Jul 15; 351(3):295-8; author reply 295-8.
    View in: PubMed
  219. Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 2004 Jul 13; 110(2):e7-12.
    View in: PubMed
  220. Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004 Jul; 148(1):99-104.
    View in: PubMed
  221. Wang PS, Ganz DA, Benner JS, Glynn RJ, Avorn J. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model. J Ment Health Policy Econ. 2004 Jun; 7(2):77-85.
    View in: PubMed
  222. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004 May 15; 93(10):1238-42.
    View in: PubMed
  223. Schneeweiss S, Wang PS, Avorn J, Maclure M, Levin R, Glynn RJ. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med. 2004 May; 19(5 Pt 1):444-50.
    View in: PubMed
  224. Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation. 2004 May 4; 109(17):2068-73.
    View in: PubMed
  225. Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, Glynn RJ. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med. 2004 Apr 12; 164(7):757-61.
    View in: PubMed
  226. Wang PS, Schneeweiss S, Glynn RJ, Mogun H, Avorn J. Use of the case-crossover design to study prolonged drug exposures and insidious outcomes. Ann Epidemiol. 2004 Apr; 14(4):296-303.
    View in: PubMed
  227. Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR, Greenland P, Ridker PM, Glynn RJ. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation. 2004 Apr 6; 109(13):1623-9.
    View in: PubMed
  228. Schneeweiss S, Maclure M, Carleton B, Glynn RJ, Avorn J. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. BMJ. 2004 Mar 6; 328(7439):560.
    View in: PubMed
  229. Glynn RJ, Rosner B. Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol. 2004 Feb; 57(2):113-22.
    View in: PubMed
  230. Albert MA, Glynn RJ, Ridker PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004 Jan 15; 93(2):221-5.
    View in: PubMed
  231. Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J. How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004 Jan; 13(1):11-9.
    View in: PubMed
  232. Dietrich T, Bernimoulin JP, Glynn RJ. The effect of cigarette smoking on gingival bleeding. J Periodontol. 2004 Jan; 75(1):16-22.
    View in: PubMed
  233. Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J. Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? Am J Med. 2003 Dec 15; 115(9):715-20.
    View in: PubMed
  234. Rosner B, Glynn RJ, Lee ML. Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics. 2003 Dec; 59(4):1089-98.
    View in: PubMed
  235. Ridker PM, Goldhaber SZ, Glynn RJ. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Nov 27; 349(22):2164-7; author reply 2164-7.
    View in: PubMed
  236. Sesso HD, Chen RS, L'Italien GJ, Lapuerta P, Lee WC, Glynn RJ. Blood pressure lowering and life expectancy based on a Markov model of cardiovascular events. Hypertension. 2003 Nov; 42(5):885-90.
    View in: PubMed
  237. Schneeweiss S, Soumerai SB, Maclure M, Dormuth C, Walker AM, Glynn RJ. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther. 2003 Oct; 74(4):388-400.
    View in: PubMed
  238. Chae CU, Albert CM, Glynn RJ, Guralnik JM, Curhan GC. Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. Am J Cardiol. 2003 Sep 15; 92(6):682-6.
    View in: PubMed
  239. Winkelmayer WC, Glynn RJ, Levin R, Avorn J. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int. 2003 Sep; 64(3):1046-9.
    View in: PubMed
  240. Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, Gaziano JM. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation. 2003 Sep 9; 108(10):1191-5.
    View in: PubMed
  241. Kurth T, Glynn RJ, Walker AM, Rexrode KM, Buring JE, Stampfer MJ, Hennekens CH, Gaziano JM. Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis. 2003 Aug; 42(2):234-44.
    View in: PubMed
  242. Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, Buring JE, Gaziano JM. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003 Aug; 14(8):2084-91.
    View in: PubMed
  243. Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003 Aug; 38(4):1103-20.
    View in: PubMed
  244. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003 Jul 15; 108(2):161-5.
    View in: PubMed
  245. Solomon DH, Glynn RJ, Bohn R, Levin R, Avorn J. The hidden cost of nonselective nonsteroidal antiinflammatory drugs in older patients. J Rheumatol. 2003 Apr; 30(4):792-8.
    View in: PubMed
  246. Parr KG, Patel MA, Dekker R, Levin R, Glynn R, Avorn J, Morse DS. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth. 2003 Apr; 17(2):176-81.
    View in: PubMed
  247. Christen WG, Manson JE, Glynn RJ, Gaziano JM, Sperduto RD, Buring JE, Hennekens CH. A randomized trial of beta carotene and age-related cataract in US physicians. Arch Ophthalmol. 2003 Mar; 121(3):372-8.
    View in: PubMed
  248. Demissie S, LaValley MP, Horton NJ, Glynn RJ, Cupples LA. Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model. Stat Med. 2003 Feb 28; 22(4):545-57.
    View in: PubMed
  249. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Apr 10; 348(15):1425-34.
    View in: PubMed
  250. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003 Jan 28; 107(3):443-7.
    View in: PubMed
  251. Duetz MS, Schneeweiss S, Maclure M, Abel T, Glynn RJ, Soumerai SB. Physician gender and changes in drug prescribing after the implementation of reference pricing in British Columbia. Clin Ther. 2003 Jan; 25(1):273-84.
    View in: PubMed
  252. Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R, Avorn J. Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry. 2002 Dec; 59(12):1147-54.
    View in: PubMed
  253. Sesso HD, Gaziano JM, VanDenburgh M, Hennekens CH, Glynn RJ, Buring JE. Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study. Control Clin Trials. 2002 Dec; 23(6):686-702.
    View in: PubMed
  254. Avorn J, Benner J, Ford I, Ganz DA, Gaw A, Glynn RJ, Jackson J, Lagaay AM, Schneeweiss S, Walley T, Wang PS. Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Control Clin Trials. 2002 Dec; 23(6):757-73.
    View in: PubMed
  255. Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
    View in: PubMed
  256. Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep; 13(9):2353-62.
    View in: PubMed
  257. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
    View in: PubMed
  258. Winkelmayer WC, Owen W, Glynn RJ, Levin R, Avorn J. Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med. 2002 Aug; 17(8):588-95.
    View in: PubMed
  259. Schneeweiss S, Maclure M, Soumerai SB, Walker AM, Glynn RJ. Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance. J Clin Epidemiol. 2002 Aug; 55(8):833-41.
    View in: PubMed
  260. Solomon DH, Glynn RJ, Avorn J. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet. 2002 Jul 6; 360(9326):90.
    View in: PubMed
  261. Avorn J, Winkelmayer WC, Bohn RL, Levin R, Glynn RJ, Levy E, Owen W. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
    View in: PubMed
  262. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002 Jul; 17(7):504-11.
    View in: PubMed
  263. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002 Jul 24-31; 288(4):455-61.
    View in: PubMed
  264. Winkelmayer WC, Glynn RJ, Levin R, Mittleman MA, Pliskin JS, Avorn J. Late nephrologist referral and access to renal transplantation. Transplantation. 2002 Jun 27; 73(12):1918-23.
    View in: PubMed
  265. Wang PS, Glynn RJ, Ganz DA, Schneeweiss S, Levin R, Avorn J. Clozapine use and risk of diabetes mellitus. J Clin Psychopharmacol. 2002 Jun; 22(3):236-43.
    View in: PubMed
  266. Solomon DH, Glynn RJ, Levin R, Avorn J. Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med. 2002 May 27; 162(10):1099-104.
    View in: PubMed
  267. Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ, Evans DA. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology. 2002 May-Jun; 21(3):123-30.
    View in: PubMed
  268. Schneeweiss S, Soumerai SB, Glynn RJ, Maclure M, Dormuth C, Walker AM. Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. CMAJ. 2002 Mar 19; 166(6):737-45.
    View in: PubMed
  269. Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med. 2002 Mar 14; 346(11):822-9.
    View in: PubMed
  270. Solomon DH, Ganz DA, Avorn J, Glynn RJ, Knight EL, Gibson CM, Stone PH. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol. 2002 Feb; 55(2):121-8.
    View in: PubMed
  271. Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 2002 Jan; 39(1):105-10.
    View in: PubMed
  272. White M, Rouleau JL, Hall C, Arnold M, Harel F, Sirois P, Greaves S, Solomon S, Ajani U, Glynn R, Hennekens C, Pfeffer M. Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction. Am Heart J. 2001 Dec; 142(6):1056-64.
    View in: PubMed
  273. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001 Dec; 49(12):1685-90.
    View in: PubMed
  274. Winkelmayer WC, Glynn RJ, Levin R, Owen WF, Avorn J. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001 Dec; 38(6):1178-84.
    View in: PubMed
  275. Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology. 2001 Nov; 12(6):682-9.
    View in: PubMed
  276. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001 Nov 1; 154(9):854-64.
    View in: PubMed
  277. Solomon DH, Stone PH, Glynn RJ, Ganz DA, Gibson CM, Tracy R, Avorn J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol. 2001 Oct; 38(4):969-76.
    View in: PubMed
  278. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension. 2001 Oct; 38(4):809-14.
    View in: PubMed
  279. Winkelmayer WC, Glynn RJ, Levin R, Owen W, Avorn J. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54.
    View in: PubMed
  280. Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol. 2001 Oct; 58(10):1640-6.
    View in: PubMed
  281. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol. 2001 Sep; 119(9):1259-65.
    View in: PubMed
  282. Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, Avorn J. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001 Aug 13-27; 161(15):1897-902.
    View in: PubMed
  283. Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, Manson JE, Hennekens CH. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol. 2001 Aug; 119(8):1143-9.
    View in: PubMed
  284. Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation. 2001 Jul 24; 104(4):393-8.
    View in: PubMed
  285. Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM. Analgesic use and renal function in men. JAMA. 2001 Jul 18; 286(3):315-21.
    View in: PubMed
  286. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry. 2001 Jun; 158(6):892-8.
    View in: PubMed
  287. Merchant SN, Incesulu A, Glynn RJ, Nadol JB. Histologic studies of the posterior stapediovestibular joint in otosclerosis. Otol Neurotol. 2001 May; 22(3):305-10.
    View in: PubMed
  288. Glynn RJ, Buring JE. Counting recurrent events in cancer research. J Natl Cancer Inst. 2001 Apr 4; 93(7):488-9.
    View in: PubMed
  289. Solomon SD, Glynn RJ, Greaves S, Ajani U, Rouleau JL, Menapace F, Arnold JM, Hennekens C, Pfeffer MA. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med. 2001 Mar 20; 134(6):451-8.
    View in: PubMed
  290. Christen WG, Ajani UA, Schaumberg DA, Glynn RJ, Manson JE, Hennekens CH. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I. Arch Ophthalmol. 2001 Mar; 119(3):405-12.
    View in: PubMed
  291. Schaumberg DA, Glynn RJ, Christen WG, Ajani UA, Stürmer T, Hennekens CH. A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol. 2001 Feb; 11(2):104-10.
    View in: PubMed
  292. Schaumberg DA, Glynn RJ, Christen WG, Hankinson SE, Hennekens CH. Relations of body fat distribution and height with cataract in men. Am J Clin Nutr. 2000 Dec; 72(6):1495-502.
    View in: PubMed
  293. Cronin-Stubbs D, de Leon CF, Beckett LA, Field TS, Glynn RJ, Evans DA. Six-year effect of depressive symptoms on the course of physical disability in community-living older adults. Arch Intern Med. 2000 Nov 13; 160(20):3074-80.
    View in: PubMed
  294. Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, Glynn RJ. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension. 2000 Nov; 36(5):801-7.
    View in: PubMed
  295. Ganz DA, Glynn RJ, Mogun H, Knight EL, Bohn RL, Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med. 2000 Nov; 15(11):776-81.
    View in: PubMed
  296. Glynn RJ, Chae CU, Guralnik JM, Taylor JO, Hennekens CH. Pulse pressure and mortality in older people. Arch Intern Med. 2000 Oct 9; 160(18):2765-72.
    View in: PubMed
  297. Knight EL, Glynn RJ, Levin R, Ganz DA, Avorn J. Failure of evidence-based medicine in the treatment of hypertension in older patients. J Gen Intern Med. 2000 Oct; 15(10):702-9.
    View in: PubMed
  298. Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Buring JE, Hennekens CH, Manson JE. Smoking cessation and risk of age-related cataract in men. JAMA. 2000 Aug 9; 284(6):713-6.
    View in: PubMed
  299. Stürmer T, Glynn RJ, Lee IM, Christen WG, Hennekens CH. Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I. J Natl Cancer Inst. 2000 Jul 19; 92(14):1178-81.
    View in: PubMed
  300. Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Manson JE, Buring JE, Hennekens CH. Baseline self-reported cataract and subsequent mortality in Physicians' Health Study I. Ophthalmic Epidemiol. 2000 Jun; 7(2):115-25.
    View in: PubMed
  301. Schaumberg DA, Christen WG, Glynn RJ, Buring JE. Demographic predictors of eye care utilization among women. Med Care. 2000 Jun; 38(6):638-46.
    View in: PubMed
  302. Glynn RJ, Rosner B. Methods to quantify the relation between disease progression in paired eyes. Am J Epidemiol. 2000 May 15; 151(10):965-74.
    View in: PubMed
  303. Velázquez-Villaseñor L, Merchant SN, Tsuji K, Glynn RJ, Wall C, Rauch SD. Temporal bone studies of the human peripheral vestibular system. Normative Scarpa's ganglion cell data. Ann Otol Rhinol Laryngol Suppl. 2000 May; 181:14-9.
    View in: PubMed
  304. Tsuji K, Velázquez-Villaseñor L, Rauch SD, Glynn RJ, Wall C, Merchant SN. Temporal bone studies of the human peripheral vestibular system. Aminoglycoside ototoxicity. Ann Otol Rhinol Laryngol Suppl. 2000 May; 181:20-5.
    View in: PubMed
  305. Tsuji K, Velázquez-Villaseñor L, Rauch SD, Glynn RJ, Wall C, Merchant SN. Temporal bone studies of the human peripheral vestibular system. Meniere's disease. Ann Otol Rhinol Laryngol Suppl. 2000 May; 181:26-31.
    View in: PubMed
  306. Merchant SN, Velázquez-Villaseñor L, Tsuji K, Glynn RJ, Wall C, Rauch SD. Temporal bone studies of the human peripheral vestibular system. Normative vestibular hair cell data. Ann Otol Rhinol Laryngol Suppl. 2000 May; 181:3-13.
    View in: PubMed
  307. Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ, Evans DA. The cross-sectional association between blood pressure and Alzheimer's disease in a biracial community population of older persons. J Gerontol A Biol Sci Med Sci. 2000 Mar; 55(3):M130-6.
    View in: PubMed
  308. Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med. 2000 Feb 28; 160(4):422-34.
    View in: PubMed
  309. Bohn RL, Gurwitz JH, Yeomans SM, Glynn RJ, Pasquale LR, Walker AM, Avorn J. Which patients are treated for glaucoma? An observational analysis. J Glaucoma. 2000 Feb; 9(1):38-44.
    View in: PubMed
  310. Stürmer T, Glynn RJ, Kliebsch U, Brenner H. Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. J Clin Epidemiol. 2000 Jan; 53(1):57-64.
    View in: PubMed
  311. Rao RS, Glynn RJ, Werler MM, Van Bennekom CM, Mitchell AA. Comparison of alternative survey methods for sensitive self-reported behaviours in a follow-up study of isotretinoin. J Epidemiol Biostat. 2000; 5(2):133-6.
    View in: PubMed
  312. Wong RJ, Keel SB, Glynn RJ, Varvares MA. Histological pattern of mandibular invasion by oral squamous cell carcinoma. Laryngoscope. 2000 Jan; 110(1):65-72.
    View in: PubMed
  313. Gaziano JM, Gaziano TA, Glynn RJ, Sesso HD, Ajani UA, Stampfer MJ, Manson JE, Hennekens CH, Buring JE. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol. 2000 Jan; 35(1):96-105.
    View in: PubMed
  314. Christen WG, Manson JE, Bubes V, Glynn RJ. Risk factors for progression of distal symmetric polyneuropathy in type 1 diabetes mellitus. Sorbinil Retinopathy Trial Research Group. Am J Epidemiol. 1999 Dec 1; 150(11):1142-51.
    View in: PubMed
  315. Berger K, Ajani UA, Kase CS, Gaziano JM, Buring JE, Glynn RJ, Hennekens CH. Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med. 1999 Nov 18; 341(21):1557-64.
    View in: PubMed
  316. Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J. 1999 Nov; 138(5 Pt 1):849-55.
    View in: PubMed
  317. O'Donnell CJ, Glynn RJ, Field TS, Averback R, Satterfield S, Friesenger GC, Taylor JO, Hennekens CH. Misclassification and under-reporting of acute myocardial infarction by elderly persons: implications for community-based observational studies and clinical trials. J Clin Epidemiol. 1999 Aug; 52(8):745-51.
    View in: PubMed
  318. Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. J Clin Epidemiol. 1999 Aug; 52(8):781-90.
    View in: PubMed
  319. Pan CX, Glynn RJ, Mogun H, Choodnovskiy I, Avorn J. Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc. 1999 Jun; 47(6):730-3.
    View in: PubMed
  320. Field TS, Gurwitz JH, Glynn RJ, Salive ME, Gaziano JM, Taylor JO, Hennekens CH. The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc. 1999 May; 47(5):507-11.
    View in: PubMed
  321. Ajani UA, Christen WG, Manson JE, Glynn RJ, Schaumberg D, Buring JE, Hennekens CH. A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann Epidemiol. 1999 Apr; 9(3):172-7.
    View in: PubMed
  322. Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol. 1999 Apr; 9(3):166-71.
    View in: PubMed
  323. Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. Am J Epidemiol. 1999 Mar 15; 149(6):541-9.
    View in: PubMed
  324. Wang PC, Merchant SN, McKenna MJ, Glynn RJ, Nadol JB. Does otosclerosis occur only in the temporal bone? Am J Otol. 1999 Mar; 20(2):162-5.
    View in: PubMed
  325. Christen WG, Ajani UA, Glynn RJ, Manson JE, Schaumberg DA, Chew EC, Buring JE, Hennekens CH. Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol. 1999 Mar 1; 149(5):476-84.
    View in: PubMed
  326. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA. 1999 Feb 17; 281(7):634-9.
    View in: PubMed
  327. Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. Current and remote blood pressure and cognitive decline. JAMA. 1999 Feb 3; 281(5):438-45.
    View in: PubMed
  328. Gaziano JM, Hennekens CH, Godfried SL, Sesso HD, Glynn RJ, Breslow JL, Buring JE. Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol. 1999 Jan 1; 83(1):52-7.
    View in: PubMed
  329. Stang A, Glynn RJ, Gann PH, Taylor JO, Hennekens CH. Cancer occurrence in the elderly: agreement between three major data sources. Ann Epidemiol. 1999 Jan; 9(1):60-7.
    View in: PubMed
  330. Christen WG, Manson JE, Glynn RJ, Ajani UA, Schaumberg DA, Sperduto RD, Buring JE, Hennekens CH. Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians. Ophthalmic Epidemiol. 1998 Sep; 5(3):133-42.
    View in: PubMed
  331. Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 1998 Jul; 105(7):1213-21.
    View in: PubMed
  332. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998 May 26; 97(20):2007-11.
    View in: PubMed
  333. Glynn RJ, Buring JE, Hennekens CH. Concerns about run-in periods in randomized trials. JAMA. 1998 May 20; 279(19):1526; author reply 1527.
    View in: PubMed
  334. Stürmer T, Glynn RJ, Lee IM, Manson JE, Buring JE, Hennekens CH. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med. 1998 May 1; 128(9):713-20.
    View in: PubMed
  335. Bohn RL, Avorn J, Glynn RJ, Choodnovskiy I, Haschemeyer R, Aledort LM. Prophylactic use of factor VIII: an economic evaluation. Thromb Haemost. 1998 May; 79(5):932-7.
    View in: PubMed
  336. Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J. Patient noncompliance in the managed care setting. The case of medical therapy for glaucoma. Med Care. 1998 Mar; 36(3):357-69.
    View in: PubMed
  337. Han WW, Incesulu A, McKenna MJ, Rauch SD, Nadol JB, Glynn RJ. Revision stapedectomy: intraoperative findings, results, and review of the literature. Laryngoscope. 1997 Sep; 107(9):1185-92.
    View in: PubMed
  338. Gurwitz JH, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol. 1997 Aug; 50(8):953-9.
    View in: PubMed
  339. Merchant SN, Wang P, Jang CH, Glynn RJ, Rauch SD, McKenna MJ, Nadol JB. Efficacy of tympanomastoid surgery for control of infection in active chronic otitis media. Laryngoscope. 1997 Jul; 107(7):872-7.
    View in: PubMed
  340. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997 Jul; 10(7 Pt 1):697-704.
    View in: PubMed
  341. Pfeffer MA, Greaves SC, Arnold JM, Glynn RJ, LaMotte FS, Lee RT, Menapace FJ, Rapaport E, Ridker PM, Rouleau JL, Solomon SD, Hennekens CH. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation. 1997 Jun 17; 95(12):2643-51.
    View in: PubMed
  342. Corti MC, Guralnik JM, Salive ME, Harris T, Ferrucci L, Glynn RJ, Havlik RJ. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997 May 15; 126(10):753-60.
    View in: PubMed
  343. Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med. 1997 Apr 1; 126(7):528-31.
    View in: PubMed
  344. O'Donnell CJ, Ridker PM, Glynn RJ, Berger K, Ajani U, Manson JE, Hennekens CH. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation. 1997 Mar 4; 95(5):1132-7.
    View in: PubMed
  345. Camargo CA, Stampfer MJ, Glynn RJ, Grodstein F, Gaziano JM, Manson JE, Buring JE, Hennekens CH. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Ann Intern Med. 1997 Mar 1; 126(5):372-5.
    View in: PubMed
  346. Rosner B, Glynn RJ. Multivariate methods for clustered ordinal data with applications to survival analysis. Stat Med. 1997 Feb 28; 16(4):357-72.
    View in: PubMed
  347. Camargo CA, Stampfer MJ, Glynn RJ, Gaziano JM, Manson JE, Goldhaber SZ, Hennekens CH. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. Circulation. 1997 Feb 4; 95(3):577-80.
    View in: PubMed
  348. Camargo CA, Hennekens CH, Gaziano JM, Glynn RJ, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med. 1997 Jan 13; 157(1):79-85.
    View in: PubMed
  349. Monane M, Gurwitz JH, Bohn RL, Glynn RJ, Levin R, Monette J, Avorn J. The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis. J Am Geriatr Soc. 1997 Jan; 45(1):71-5.
    View in: PubMed
  350. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996 Dec; 86(12):1805-8.
    View in: PubMed
  351. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA. 1996 Oct 9; 276(14):1147-51.
    View in: PubMed
  352. Monane M, Kanter DS, Glynn RJ, Avorn J. Variability in length of hospitalization for stroke. The role of managed care in an elderly population. Arch Neurol. 1996 Sep; 53(9):875-80.
    View in: PubMed
  353. Zhang Y, Glynn RJ, Felson DT. Musculoskeletal disease research: should we analyze the joint or the person? J Rheumatol. 1996 Jul; 23(7):1130-4.
    View in: PubMed
  354. Glynn RJ, Hennekens CH. CHD in the elderly: knowledge for clinicians and researchers. Aging (Milano). 1996 Apr; 8(2):73-4.
    View in: PubMed
  355. Stürmer T, Glynn RJ, Field TS, Taylor JO, Hennekens CH. Aspirin use and cognitive function in the elderly. Am J Epidemiol. 1996 Apr 1; 143(7):683-91.
    View in: PubMed
  356. Rosbe KW, Burgess BJ, Glynn RJ, Nadol JB. Morphologic evidence for three cell types in the human spiral ganglion. Hear Res. 1996 Apr; 93(1-2):120-7.
    View in: PubMed
  357. Gurwitz JH, Everitt DE, Monane M, Glynn RJ, Choodnovskiy I, Beaudet MP, Avorn J. The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci. 1996 Mar; 51(2):M74-9.
    View in: PubMed
  358. Glynn RJ, Buring JE. Ways of measuring rates of recurrent events. BMJ. 1996 Feb 10; 312(7027):364-7.
    View in: PubMed
  359. Monane M, Glynn RJ, Avorn J. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin Pharmacol Ther. 1996 Jan; 59(1):83-92.
    View in: PubMed
  360. Christen WG, Glynn RJ, Hennekens CH. Antioxidants and age-related eye disease. Current and future perspectives. Ann Epidemiol. 1996 Jan; 6(1):60-6.
    View in: PubMed
  361. Glynn RJ, Brock DB, Harris T, Havlik RJ, Chrischilles EA, Ostfeld AM, Taylor JO, Hennekens CH. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med. 1995 Sep 25; 155(17):1855-60.
    View in: PubMed
  362. Glynn RJ, Christen WG, Manson JE, Bernheimer J, Hennekens CH. Body mass index. An independent predictor of cataract. Arch Ophthalmol. 1995 Sep; 113(9):1131-7.
    View in: PubMed
  363. Kalish SC, Bohn RL, Mogun H, Glynn RJ, Gurwitz JH, Avorn J. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people. J Am Geriatr Soc. 1995 Sep; 43(9):967-73.
    View in: PubMed
  364. Corti MC, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB, Berkman LF, Seeman TE, Glynn RJ, Hennekens CH, et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 1995 Aug 16; 274(7):539-44.
    View in: PubMed
  365. Buring JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA. 1995 Aug 23-30; 274(8):654-5.
    View in: PubMed
  366. Monane M, Gurwitz JH, Lipsitz LA, Glynn RJ, Choodnovskiy I, Avorn J. Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. J Am Geriatr Soc. 1995 Jun; 43(6):618-22.
    View in: PubMed
  367. Monane M, Glynn RJ, Gurwitz JH, Bohn RL, Levin R, Avorn J. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension. 1995 May; 25(5):1045-51.
    View in: PubMed
  368. Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet. 1995 Apr 1; 345(8953):825-9.
    View in: PubMed
  369. Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH. Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study. Arch Intern Med. 1994 Dec 12-26; 154(23):2649-57.
    View in: PubMed
  370. Gurwitz JH, Field TS, Glynn RJ, Manson JE, Avorn J, Taylor JO, Hennekens CH. Risk factors for non-insulin-dependent diabetes mellitus requiring treatment in the elderly. J Am Geriatr Soc. 1994 Dec; 42(12):1235-40.
    View in: PubMed
  371. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994 Sep 28; 272(12):929-33.
    View in: PubMed
  372. Stukel TA, Glynn RJ, Fisher ES, Sharp SM, Lu-Yao G, Wennberg JE. Standardized rates of recurrent outcomes. Stat Med. 1994 Sep 15; 13(17):1781-91.
    View in: PubMed
  373. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994 Sep 14; 272(10):781-6.
    View in: PubMed
  374. Christen WG, Glynn RJ, Seddon JM, Manson JE, Buring JE, Hennekens CH. Confirmation of self-reported cataract in the Physicians' Health Study. Ophthalmic Epidemiol. 1994 Jun; 1(2):85-91.
    View in: PubMed
  375. Glynn RJ, Rosner B. Comparison of alternative regression models for paired binary data. Stat Med. 1994 May 30; 13(10):1023-36.
    View in: PubMed
  376. Seddon JM, Christen WG, Manson JE, LaMotte FS, Glynn RJ, Buring JE, Hennekens CH. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health. 1994 May; 84(5):788-92.
    View in: PubMed
  377. Manson JE, Christen WG, Seddon JM, Glynn RJ, Hennekens CH. A prospective study of alcohol consumption and risk of cataract. Am J Prev Med. 1994 May-Jun; 10(3):156-61.
    View in: PubMed
  378. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994 Mar 9; 271(10):751-4.
    View in: PubMed
  379. Turco PD, Connolly J, McCabe P, Glynn RJ. Assessment of functional vision performance: a new test for low vision patients. Ophthalmic Epidemiol. 1994 Mar; 1(1):15-25.
    View in: PubMed
  380. Salive ME, Guralnik J, Glynn RJ, Christen W, Wallace RB, Ostfeld AM. Association of visual impairment with mobility and physical function. J Am Geriatr Soc. 1994 Mar; 42(3):287-92.
    View in: PubMed
  381. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994 Mar; 49(2):M85-94.
    View in: PubMed
  382. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994 Feb 28; 154(4):433-7.
    View in: PubMed
  383. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med. 1994 Jan 10; 154(1):97-101.
    View in: PubMed
  384. Bohn RL, Glynn RJ, Gurwitz JH, Everitt DE, Gilden D, Avorn J. Patterns of glaucoma medication use in the elderly: 1980-1990. J Glaucoma. 1994; 3(3):259-64.
    View in: PubMed
  385. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Choodnovskiy I, Avorn J. Topical glaucoma medications and cardiovascular risk in the elderly. Clin Pharmacol Ther. 1994 Jan; 55(1):76-83.
    View in: PubMed
  386. Fulton AB, Hansen RM, Glynn RJ. Natural course of visual functions in the Bardet-Biedl syndrome. Arch Ophthalmol. 1993 Nov; 111(11):1500-6.
    View in: PubMed
  387. Glynn RJ, Field TS, Satterfield S, Hebert PR, Buring JE, Taylor JO, Hennekens CH. Modification of increasing systolic blood pressure in the elderly during the 1980s. Am J Epidemiol. 1993 Sep 15; 138(6):365-79.
    View in: PubMed
  388. Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Choodnovskiy I, Avorn J. Old age and race as determinants of initiation of glaucoma therapy. Am J Epidemiol. 1993 Sep 15; 138(6):395-406.
    View in: PubMed
  389. Shingleton BJ, Richter CU, Dharma SK, Tong L, Bellows AR, Hutchinson BT, Glynn RJ. Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmology. 1993 Sep; 100(9):1324-9.
    View in: PubMed
  390. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 1993 Aug 4; 85(15):1220-4.
    View in: PubMed
  391. Seeman TE, Berkman LF, Kohout F, Lacroix A, Glynn R, Blazer D. Intercommunity variations in the association between social ties and mortality in the elderly. A comparative analysis of three communities. Ann Epidemiol. 1993 Jul; 3(4):325-35.
    View in: PubMed
  392. Chiong CM, Xu WZ, Glynn RJ, Nadol JB. Survival of Scarpa's ganglion in the profoundly deaf human. Ann Otol Rhinol Laryngol. 1993 Jun; 102(6):425-8.
    View in: PubMed
  393. Mangione CM, Seddon JM, Cook EF, Krug JH, Sahagian CR, Campion EW, Glynn RJ. Correlates of cognitive function scores in elderly outpatients. J Am Geriatr Soc. 1993 May; 41(5):491-7.
    View in: PubMed
  394. Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993 May; 83(5):711-6.
    View in: PubMed
  395. Glynn RJ, Stukel TA, Sharp SM, Bubolz TA, Freeman JL, Fisher ES. Estimating the variance of standardized rates of recurrent events, with application to hospitalizations among the elderly in New England. Am J Epidemiol. 1993 Apr 1; 137(7):776-86.
    View in: PubMed
  396. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993 Mar 8; 153(5):578-81.
    View in: PubMed
  397. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993 Feb 15; 118(4):273-8.
    View in: PubMed
  398. Salive ME, Guralnik JM, Glynn RJ. Left-handedness and mortality. Am J Public Health. 1993 Feb; 83(2):265-7.
    View in: PubMed
  399. Avorn J, Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Everitt DE, Gilden D, Choodnovskiy I. Adverse pulmonary effects of topical Beta blockers used in the treatment of glaucoma. J Glaucoma. 1993; 2(3):158-65.
    View in: PubMed
  400. Rosen HN, Maitland LA, Suttie JW, Manning WJ, Glynn RJ, Greenspan SL. Vitamin K and maintenance of skeletal integrity in adults. Am J Med. 1993 Jan; 94(1):62-8.
    View in: PubMed
  401. Salive ME, Guralnik J, Christen W, Glynn RJ, Colsher P, Ostfeld AM. Functional blindness and visual impairment in older adults from three communities. Ophthalmology. 1992 Dec; 99(12):1840-7.
    View in: PubMed
  402. Nadol JB, Chiong CM, Ojemann RG, McKenna MJ, Martuza RL, Montgomery WW, Levine RA, Ronner SF, Glynn RJ. Preservation of hearing and facial nerve function in resection of acoustic neuroma. Laryngoscope. 1992 Oct; 102(10):1153-8.
    View in: PubMed
  403. Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, Glynn RJ, Ostfeld AM, Guralnik JM. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol. 1992 Sep; 47(5):M137-44.
    View in: PubMed
  404. Christen WG, Manson JE, Seddon JM, Glynn RJ, Buring JE, Rosner B, Hennekens CH. A prospective study of cigarette smoking and risk of cataract in men. JAMA. 1992 Aug 26; 268(8):989-93.
    View in: PubMed
  405. Seddon JM, Egan KM, Zhang Y, Gelles EJ, Glynn RJ, Tucker CA, Gragoudas ES. Evaluation of skin microtopography as a measure of ultraviolet exposure. Invest Ophthalmol Vis Sci. 1992 May; 33(6):1903-8.
    View in: PubMed
  406. Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol. 1992 Apr; 110(4):475-9.
    View in: PubMed
  407. Glynn RJ, Rosner B. Accounting for the correlation between fellow eyes in regression analysis. Arch Ophthalmol. 1992 Mar; 110(3):381-7.
    View in: PubMed
  408. de Labry LO, Glynn RJ, Levenson MR, Hermos JA, LoCastro JS, Vokonas PS. Alcohol consumption and mortality in an American male population: recovering the U-shaped curve--findings from the normative Aging Study. J Stud Alcohol. 1992 Jan; 53(1):25-32.
    View in: PubMed
  409. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991 Mar; 98(3):383-9; discussion 390.
    View in: PubMed
  410. Glynn RJ, Seddon JM, Krug JH, Sahagian CR, Chiavelli ME, Campion EW. Falls in elderly patients with glaucoma. Arch Ophthalmol. 1991 Feb; 109(2):205-10.
    View in: PubMed
  411. Glynn RJ, Schein OD, Seddon JM, Poggio EC, Goodfellow JR, Scardino VA, Shannon MJ, Kenyon KR. The incidence of ulcerative keratitis among aphakic contact lens wearers in New England. Arch Ophthalmol. 1991 Jan; 109(1):104-7.
    View in: PubMed
  412. Khetarpal U, Nadol JB, Glynn RJ. Idiopathic sudden sensorineural hearing loss and postnatal viral labyrinthitis: a statistical comparison of temporal bone findings. Ann Otol Rhinol Laryngol. 1990 Dec; 99(12):969-76.
    View in: PubMed
  413. Austin KL, Palmer JR, Seddon JM, Glynn RJ, Rosenberg L, Gragoudas ES, Kaufman DW, Shapiro S. Case-control study of idiopathic retinal detachment. Int J Epidemiol. 1990 Dec; 19(4):1045-50.
    View in: PubMed
  414. Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol. 1990 Sep; 108(9):1274-80.
    View in: PubMed
  415. Seddon JM, Sahagian CR, Glynn RJ, Sperduto RD, Gragoudas ES. Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. Invest Ophthalmol Vis Sci. 1990 Aug; 31(8):1592-8.
    View in: PubMed
  416. Oliveira CA, Schuknecht HF, Glynn RJ. In search of cochlear morphologic correlates for tinnitus. Arch Otolaryngol Head Neck Surg. 1990 Aug; 116(8):937-9.
    View in: PubMed
  417. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 1990 Jun; 97(6):769-77.
    View in: PubMed
  418. de Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol. 1990; 43(2):153-7.
    View in: PubMed
  419. Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology. 1989 Dec; 96(12):1716-21.
    View in: PubMed
  420. Glynn RJ, Seddon JM, Gragoudas ES, Egan KM, Hart LJ. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma. Ophthalmology. 1989 Oct; 96(10):1566-73.
    View in: PubMed
  421. Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group. N Engl J Med. 1989 Sep 21; 321(12):773-8.
    View in: PubMed
  422. Poggio EC, Glynn RJ, Schein OD, Seddon JM, Shannon MJ, Scardino VA, Kenyon KR. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med. 1989 Sep 21; 321(12):779-83.
    View in: PubMed
  423. Egan KM, Gragoudas ES, Seddon JM, Glynn RJ, Munzenreider JE, Goitein M, Verhey L, Urie M, Koehler A. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 1989 Sep; 96(9):1377-82; discussion 1382-3.
    View in: PubMed
  424. Flotte TJ, Seddon JM, Zhang YQ, Glynn RJ, Egan KM, Gragoudas ES. A computerized image analysis method for measuring elastic tissue. J Invest Dermatol. 1989 Sep; 93(3):358-62.
    View in: PubMed
  425. Ekerdt DJ, De Labry LO, Glynn RJ, Davis RW. Change in drinking behaviors with retirement: findings from the normative aging study. J Stud Alcohol. 1989 Jul; 50(4):347-53.
    View in: PubMed
  426. Nadol JB, Young YS, Glynn RJ. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol. 1989 Jun; 98(6):411-6.
    View in: PubMed
  427. Gudmundsson OG, Ormerod LD, Kenyon KR, Glynn RJ, Baker AS, Haaf J, Lubars S, Abelson MB, Boruchoff SA, Foster CS, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989; 8(2):115-21.
    View in: PubMed
  428. Friedman E, Ivry M, Ebert E, Glynn R, Gragoudas E, Seddon J. Increased scleral rigidity and age-related macular degeneration. Ophthalmology. 1989 Jan; 96(1):104-8.
    View in: PubMed
  429. Polivogianis L, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Comparison of transillumination and histologic slide measurements of tumor diameter in uveal melanoma. Ophthalmology. 1988 Nov; 95(11):1576-82.
    View in: PubMed
  430. Hermos JA, Locastro JS, Glynn RJ, Bouchard GR, De Labry LO. Predictors of reduction and cessation of drinking in community-dwelling men: results from the normative aging study. J Stud Alcohol. 1988 Jul; 49(4):363-8.
    View in: PubMed
  431. Gragoudas ES, Seddon JM, Egan KM, Glynn RJ, Goitein M, Munzenrider J, Verhey L, Urie M, Koehler A. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 1988 Jul; 95(7):992-9.
    View in: PubMed
  432. Glynn RJ, Seddon JM, Berlin BM. The incidence of eye injuries in New England adults. Arch Ophthalmol. 1988 Jun; 106(6):785-9.
    View in: PubMed
  433. Glynn RJ, de Labry LO, Hou DM. Alcohol consumption, type A behavior, and demographic variables. Results from the Normative Aging Study. Am J Epidemiol. 1988 Feb; 127(2):310-20.
    View in: PubMed
  434. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988 Jan-Feb; 32(4):239-51.
    View in: PubMed
  435. Campion EW, deLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the Normative Aging Study. J Gerontol. 1988 Jan; 43(1):M18-20.
    View in: PubMed
  436. Shingleton BJ, Richter CU, Bellows AR, Hutchinson BT, Glynn RJ. Long-term efficacy of argon laser trabeculoplasty. Ophthalmology. 1987 Dec; 94(12):1513-8.
    View in: PubMed
  437. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Munzenrider JE, Austin-Seymour M, Goitein M, Verhey L, Urie M, Koehler A. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology. 1987 Apr; 94(4):354-61.
    View in: PubMed
  438. Gragoudas ES, Seddon JM, Egan K, Glynn R, Munzenrider J, Austin-Seymour M, Goitein M, Verhey L, Urie M, Koehler A. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 1987 Apr; 94(4):349-53.
    View in: PubMed
  439. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987 Mar; 82(3):421-6.
    View in: PubMed
  440. Glynn RJ, Bouchard GR, LoCastro JS, Laird NM. Aging and generational effects on drinking behaviors in men: results from the normative aging study. Am J Public Health. 1985 Dec; 75(12):1413-9.
    View in: PubMed
  441. Ekerdt DJ, Bosse R, Glynn RJ. Period effects on planned age for retirement, 1975-1984. Findings from the Normative Aging Study. Res Aging. 1985 Sep; 7(3):395-407.
    View in: PubMed
  442. Glynn RJ, Campion EW, Bouchard GR, Silbert JE. The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol. 1985 Jan; 121(1):78-90.
    View in: PubMed
  443. Sparrow D, Glynn RJ, Cohen M, Weiss ST. The relationship of the peripheral leukocyte count and cigarette smoking to pulmonary function among adult men. Chest. 1984 Sep; 86(3):383-6.
    View in: PubMed
  444. Ekerdt DJ, Sparrow D, Glynn RJ, Bossé R. Change in blood pressure and total cholesterol with retirement. Am J Epidemiol. 1984 Jul; 120(1):64-71.
    View in: PubMed
  445. Glynn RJ, LoCastro JS, Hermos JA, Bossé R. Social contexts and motives for drinking in men. J Stud Alcohol. 1983 Nov; 44(6):1011-25.
    View in: PubMed
  446. Borkan GA, Hults DE, Glynn RJ. Role of longitudinal change and secular trend in age differences in male body dimensions. Hum Biol. 1983 Sep; 55(3):629-41.
    View in: PubMed
  447. Garvey AJ, Bossé R, Glynn RJ, Rosner B. Smoking cessation in a prospective study of healthy adult males: effects of age, time period, and amount smoked. Am J Public Health. 1983 Apr; 73(4):446-50.
    View in: PubMed
  448. Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961--1980. Arthritis Rheum. 1983 Jan; 26(1):87-93.
    View in: PubMed
  449. Glynn RJ, Rosner B, Silbert JE. Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men. Circulation. 1982 Oct; 66(4):724-31.
    View in: PubMed
  450. Chao FC, Tullis JL, Alper CA, Glynn RJ, Silbert JE. Alteration in plasma proteins and platelet functions with aging and cigarette smoking in healthy men. Thromb Haemost. 1982 Jun 28; 47(3):259-64.
    View in: PubMed
  451. Borkan GA, Glynn RJ, Bachman SS, Bossé R, Weiss ST. Relationship between cigarette smoking, chest size and body size in health-screened adult males. Ann Hum Biol. 1981 Mar-Apr; 8(2):153-60.
    View in: PubMed
  452. Bossé R, Garvery AJ, Glynn RJ. Age and addiction to smoking. Addict Behav. 1980; 5(4):341-51.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu. SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu).
Glynn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_